The 'miracle' of the ivory-billed woodpecker

By now, you have no doubt heard that three biologists are putting into serious question the reappearance of the ivory-billed woodpecker in the southern US. See the Girl Scientist?s blog for some interesting commentary and a lengthy interview with Tim Gallagher, one of the authors of the original Science report on the find.The New York Times covered the skeptical scientists yesterday (July 21). But one thing yesterday?s story neglected to mention was the Times? own awestruck editorial, on Apr

Written byIvan Oransky
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
By now, you have no doubt heard that three biologists are putting into serious question the reappearance of the ivory-billed woodpecker in the southern US. See the Girl Scientist?s blog for some interesting commentary and a lengthy interview with Tim Gallagher, one of the authors of the original Science report on the find.The New York Times covered the skeptical scientists yesterday (July 21). But one thing yesterday?s story neglected to mention was the Times? own awestruck editorial, on April 30, on the original report in Science. In it, they came as close to calling the bird?s reappearance a miracle as you can without actually calling it one. An excerpt:?The ivory-billed woodpecker is a living monument to the stubbornness of all creatures that refuse to be erased, despite all our blundering and destructive habits. Its odd nickname is a fitting tribute: not ''Wow,'' ''Geez'' or ''Check it out,'' but ''Lord God,'' two words that capture the moment when the eyes widen, the muscles go slack and the mind reels at the wondrous things with which we share the world.?Here?s the passage that probably clinched the decision for reporters and editors working on the most recent story: ?The word miracle is overused, but what else explains the survival in the 21st century of an animal considered lost to history so long ago?? That?s certainly a good question. The answer just might be ?bad data.?
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies